CLZ-2002
- Generic Name
- CLZ-2002
- Drug Type
- Biotech
- Background
CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells.
The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Cellatoz Therapeutics, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT05947578
- Locations
- 🇰🇷
Samsung Medical center, Seoul, Gangnam-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath